1-20 of 24
Daniel Lindner
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Abstract 1088: Advancing non-cytotoxic DNMT1-targeting to treat chemorefractory pancreatic cancer

Rita Tohme, Francis Enane, Caroline Schuerger, Xiaorong Gu, Melissa Fishel, John Pink, Daniel Lindner, Davendra Sohal, Yogen Saunthararajah
Journal: Cancer Research
Cancer Res (2021) 81 (13_Supplement): 1088.
https://doi.org/10.1158/1538-7445.AM2021-1088
Published: 01 July 2021
View article titled, Abstract 1088: Advancing non-cytotoxic DNMT1-targeting to treat chemorefractory pancreatic cancer
Journal Articles

Abstract C58: p53/p16-independent cytoreduction of chemoresistant pancreatic adenocarcinoma by metabolically optimized epigenetic therapy

Rita Tohme, Xiaorong Gu, Asmaa El Desoky, Caroline Schuerger, Daniel Lindner, Davendra Sohal, Yogen Saunthararajah
Journal: Cancer Research
Cancer Res (2019) 79 (24_Supplement): C58.
https://doi.org/10.1158/1538-7445.PANCA19-C58
Published: 13 December 2019
View article titled, Abstract C58: p53/p16-independent cytoreduction of chemoresistant pancreatic adenocarcinoma by metabolically optimized epigenetic therapy
Journal Articles

Abstract 2531: Regulation of androgen signaling axis and tumor suppressive function of miR-149-5p in prostate cancer

Savita Singh, Jey Sabith Ebron, Eswar Shankar, Sanjay Gupta, Daniel Lindner, Girish Shukla
Journal: Cancer Research
Cancer Res (2017) 77 (13_Supplement): 2531.
https://doi.org/10.1158/1538-7445.AM2017-2531
Published: 01 July 2017
View article titled, Abstract 2531: Regulation of androgen signaling axis and tumor suppressive function of miR-149-5p in prostate cancer
Journal Articles

Abstract 3520: PBRM1 inactivation in renal cell cancer alters master transcription factor hub composition to repress instead of activate epithelial-differentiation

Xiaorong Gu, Francis Enane, Reda Mahfouz, Tomas Radivoyevitch, Bartlomiej Przychodzen, Yvonne Parker, Daniel Lindner, Brian Rini, Yogen Saunthararajah
Journal: Cancer Research
Cancer Res (2017) 77 (13_Supplement): 3520.
https://doi.org/10.1158/1538-7445.AM2017-3520
Published: 01 July 2017
View article titled, Abstract 3520: PBRM1 inactivation in renal cell cancer alters master transcription factor hub composition to repress instead of activate epithelial-differentiation
Journal Articles

Abstract 3036: Targeting FACT complex with CBL0137 to overcome acquired resistance to EGFR-TKI in lung adenocarcinoma

Neelesh Sharma, Josephine Dermawan, Andrei Purmal, Daniel Lindner, Gary Wildey, Afshin Dowlati, Andrei Gudkov, Katerina Gurova, George R. Stark
Journal: Cancer Research
Cancer Res (2016) 76 (14_Supplement): 3036.
https://doi.org/10.1158/1538-7445.AM2016-3036
Published: 15 July 2016
View article titled, Abstract 3036: Targeting FACT complex with CBL0137 to overcome acquired resistance to EGFR-TKI in lung adenocarcinoma
Journal Articles

Abstract 1295: Evaluation of the efficacy of TRAIL plus quercetin as a potential breast carcinoma therapeutic

Jasmine M. Manouchehri, Michael Kalafatis, Daniel Lindner
Journal: Cancer Research
Cancer Res (2016) 76 (14_Supplement): 1295.
https://doi.org/10.1158/1538-7445.AM2016-1295
Published: 15 July 2016
View article titled, Abstract 1295: Evaluation of the efficacy of TRAIL plus quercetin as a potential breast carcinoma therapeutic
Journal Articles

Abstract 1294: Sensitization of malignant melanomas to TRAIL-induced apoptosis by quercetin

Katherine Turner, Daniel Lindner, Michael Kalafatis
Journal: Cancer Research
Cancer Res (2016) 76 (14_Supplement): 1294.
https://doi.org/10.1158/1538-7445.AM2016-1294
Published: 15 July 2016
View article titled, Abstract 1294: Sensitization of malignant melanomas to TRAIL-induced apoptosis by quercetin
Journal Articles

Abstract B34: Sensitization of TRAIL-resistant malignant melanomas by ellagic acid

Katherine A. Turner, Daniel Lindner, Michael Kalafatis
Journal: Cancer Research
Cancer Res (2015) 75 (14_Supplement): B34.
https://doi.org/10.1158/1538-7445.MEL2014-B34
Published: 16 July 2015
View article titled, Abstract B34: Sensitization of TRAIL-resistant malignant melanomas by ellagic acid
Journal Articles

Abstract 1835: Transcriptome and metabolome reprogramming in EGFR-mutant NSCLC early adaptive drug-escape against erlotinib

Patrick C. Ma, Praveena S. Thiagarajan, Patrick Leahy, Rakesh Bagai, Ivy Shi, Wei Zhang, Yan Feng, Martina L. Veigl, Daniel Lindner, David Danielpour, Lihong Yin
Journal: Cancer Research
Cancer Res (2014) 74 (19_Supplement): 1835.
https://doi.org/10.1158/1538-7445.AM2014-1835
Published: 01 October 2014
View article titled, Abstract 1835: Transcriptome and metabolome reprogramming in EGFR-mutant NSCLC early adaptive drug-escape against erlotinib
Journal Articles

Abstract 2088: Kindlin-3 enhances breast cancer metastasis through upregulation of Twist-mediated tumor angiogenesis

Khalid Sossey-Alaoui, Elzbieta Pluskota, Gangarao Davuluri, Katarzyna Bialkowska, Mitali Das, Daniel Lindner, Edward F. Plow
Journal: Cancer Research
Cancer Res (2014) 74 (19_Supplement): 2088.
https://doi.org/10.1158/1538-7445.AM2014-2088
Published: 01 October 2014
View article titled, Abstract 2088: Kindlin-3 enhances breast cancer metastasis through upregulation of Twist-mediated tumor angiogenesis
Journal Articles

Abstract 3718: Adaptive drug escape of EML4-ALK lung cancer against targeted ALK inhibitor involving TGFβ2-mitochondrial priming

Lihong Yin, Wei Zhang, Ivy Shi, Yan Feng, Rakesh Bagai, Daniel Lindner, Patrick C. Ma
Journal: Cancer Research
Cancer Res (2014) 74 (19_Supplement): 3718.
https://doi.org/10.1158/1538-7445.AM2014-3718
Published: 01 October 2014
View article titled, Abstract 3718: Adaptive drug escape of EML4-ALK lung cancer against targeted ALK inhibitor involving TGFβ2-mitochondrial priming
Journal Articles

Abstract 2289: Effects of TRAIL and ellagic acid on malignant melanoma A375 in vitro and in vivo

Katherine Turner, Daniel Lindner, Michael Kalafatis
Journal: Cancer Research
Cancer Res (2014) 74 (19_Supplement): 2289.
https://doi.org/10.1158/1538-7445.AM2014-2289
Published: 01 October 2014
View article titled, Abstract 2289: Effects of TRAIL and ellagic acid on malignant melanoma A375 in vitro and in vivo
Journal Articles

Abstract 3336: The Smac Mimetic Birinapant Synergistically Induces Apoptosis in Combination with Type I Interferons and GM-CSF.

Christopher A. Benetatos, Jennifer M. Burns, Ernest C. Borden, Daniel Lindner, Yasuhiro Mitsuuchi, Mark A. Mckinlay, Gurpreet Singh Kapoor, Eric M. Neiman, Martin E. Seipel, Guangyao Yu, Martin Graham, David Weng, Stephen M. Condon, C. Glenn Begley, Srinivas Chunduru
Journal: Cancer Research
Cancer Res (2013) 73 (8_Supplement): 3336.
https://doi.org/10.1158/1538-7445.AM2013-3336
Published: 15 April 2013
View article titled, Abstract 3336: The Smac Mimetic Birinapant Synergistically Induces Apoptosis in Combination with Type I Interferons and GM-CSF.
Journal Articles

Abstract 868: Oral SHP-1 inhibitor TPI-1a4 increases TILs in melanoma tumors and interacts positively with CTLA4 antibody for melanoma cure in mice

Taolin Yi, Daniel Lindner, Ralph Tuthill, Hans Loibner, Ernest Borden
Journal: Cancer Research
Cancer Res (2012) 72 (8_Supplement): 868.
https://doi.org/10.1158/1538-7445.AM2012-868
Published: 15 April 2012
View article titled, Abstract 868: Oral SHP-1 inhibitor TPI-1a4 increases TILs in melanoma tumors and interacts positively with CTLA4 antibody for melanoma cure in mice
Journal Articles

Noncytotoxic Differentiation Treatment of Renal Cell Cancer

Soledad Negrotto, Zhenbo Hu, Oscar Alcazar, Kwok Peng Ng, Pierre Triozzi, Daniel Lindner, Brian Rini, Yogen Saunthararajah
Journal: Cancer Research
Cancer Res (2011) 71 (4): 1431–1441.
https://doi.org/10.1158/0008-5472.CAN-10-2422
Published: 14 February 2011
View article titled, Noncytotoxic Differentiation Treatment of Renal Cell Cancer
Open the PDF for Noncytotoxic Differentiation Treatment of Renal Cell Cancer in another window
Includes: Supplementary data
Journal Articles

Abstract #1771: Anti-tumor effects of nitrosylcobalamin (NO-Cbl) against spontaneous tumors in dogs

Joseph Bauer, Gerald Frye, Anne Bahr, Jennifer Gieg, Daniel Lindner
Journal: Cancer Research
Cancer Res (2009) 69 (9_Supplement): 1771.
Published: 01 May 2009
View article titled, Abstract #1771: Anti-tumor effects of nitrosylcobalamin (NO-Cbl) against spontaneous tumors in dogs
Journal Articles

Abstract #4531: Antitumor effects of N-heterocylic carbene silver acetate complexes compared to cisplatin, carboplatin and oxaliplatin

Lauren Ogrich, Caroline Garber, Joseph Bauer, Stephanie Sielski, Rebecca Haney, Khadijah Hindi, Amanda Knapp, Matthew Panzner, Wiley Youngs, Daniel Lindner
Journal: Cancer Research
Cancer Res (2009) 69 (9_Supplement): 4531.
Published: 01 May 2009
View article titled, Abstract #4531: Antitumor effects of N-heterocylic carbene silver acetate complexes compared to cisplatin, carboplatin and oxaliplatin
Journal Articles

Synthesis, characterization and antitumor activity of N-heterocyclic carbene silver acetate complexes

Doug Medvetz, Khadijah Hindi, Matthew Panzner, Andrew Ditto, Yang Yun, Lauren Ogrich, Joseph Bauer, Daniel Lindner, Wiley Youngs
Journal: Cancer Research
Cancer Res (2008) 68 (9_Supplement): 5680.
Published: 01 May 2008
View article titled, Synthesis, characterization and antitumor activity of N-heterocyclic carbene silver acetate complexes
Journal Articles

Treating CNS tumors with nitrosylcobalamin: Improving upon Apo2L/TRAIL, radiation, and temozolomide therapies

Joseph Bauer, Lauren Ogrich, Rebecca Lee, Rebecca Haney, Bei Morrison, Joseph Lupica, Jennifer Cutter, Nabila Bennani-Baiti, Joseph DiDonato, Michael Vogelbaum, Daniel Lindner
Journal: Cancer Research
Cancer Res (2008) 68 (9_Supplement): 4046.
Published: 01 May 2008
View article titled, Treating CNS tumors with nitrosylcobalamin: Improving upon Apo2L/TRAIL, radiation, and temozolomide therapies
Journal Articles

Effect of dosing schedule of 5-aza-2'deoxycytidine (5-AZA-dC)on melanoma xenografts to determine efficacy, toxicity, and demethylation of target genes

Barbara Jacobs, Venugopalan Cheriyath, Rebecca Haney, Daniel Lindner, Ernest Borden
Journal: Cancer Research
Cancer Res (2007) 67 (9_Supplement): 2205.
Published: 01 May 2007
View article titled, Effect of dosing schedule of 5-aza-2'deoxycytidine (5-AZA-dC)on melanoma xenografts to determine efficacy, toxicity, and demethylation of target genes